← Eichor
Study identifier: NCT07477236 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

MyVitalC: Sleep and Everyday Headache Management

Condition: Sleep · Headaches  ·  Sponsor: Efforia, Inc

PhaseNA
Planned participants100
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersYes

About this study

Sleep disturbance and recurring headaches can negatively affect daily functioning, mood, and productivity. MyVitalC (ESS60 in extra virgin olive oil) is a commercially available dietary supplement that has generated anecdotal claims related to sleep quality and headache relief; however, human data remain limited. This real-world observational study is designed to help participants evaluate whether use of MyVitalC is associated with changes in sleep disturbance and headache frequency or severity in their own daily lives. Participants will complete a four-week baseline observation period without the intervention, followed by six weeks of daily MyVitalC use, with weekly self-reported assessments. Participants serve as their own control, allowing for within-person comparison of outcomes before and during product use.

This description comes directly from the study's public registry record.

Talk to the study team

Matthew Amsden  ·  (646) 679-2479  ·  help@efforia.com

Always discuss trial participation with your own doctor first.

Locations (1)

EfforiaNew York, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07477236